The impact of zinc supplementation and serum zinc levels on glycemic control in type 2 diabetes mellitus
Keywords:
zinc supplementation, serum zinc levels, glycemic control, type 2 diabetes mellitusAbstract
Introduction: Diabetes mellitus (DM) is a chronic metabolic disorder that requires a multifaceted approach to manage the disease, including lifestyle changes, medication, and monitoring blood glucose levels. Zinc is an essential micronutrient that plays a critical role in regulating insulin secretion, glucose metabolism, and immune function. Zinc supplementation may improve glycemic control and reduce oxidative stress in people with type 2 DM. Objectives: To determine whether zinc supplementation can enhance glycemic control in type 2 diabetic patients by investigating the relationship between serum zinc levels and glycemic control. Methodology: 100 participants with type 2 DM were recruited from local DM clinics and hospitals to participate in the study. Fifty participants were assigned to the zinc supplementation group and fifty to the placebo group. At the beginning and conclusion of the 12-week study period, serum zinc, HbA1c, and fasting plasma glucose levels were measured using blood samples. Using the t-test and regression analysis, SPSS (version 23.0) was used to conduct statistical analysis. Results: The mean age of the participants was 58.2 years, and the majority had a BMI greater than 25. There were no significant differences between the two categories in terms of participant characteristics.
Downloads
References
American DM Association. (2022). Diagnosis and classification of DM mellitus. DM Care, 45(Supplement 1), S141-S153. doi: 10.2337/dc22-S001
Ghasemi, A., Zahediasl, S., Hosseini-Esfahani, F., & Azizi, F. (2012). Reference values for serum zinc concentration and prevalence of zinc deficiency in adult Iranian subjects. Biological trace element research, 149(3), 307–314. https://doi.org/10.1007/s12011-012-9445-2
Huang, J., Jiang, Y., Zhang, Z., Zhang, R., & Ji, T. (2018). The Zinc Transporter SLC39A7 (ZIP7) Is Essential for Regulation of Cytosolic Zinc Levels. Journal of Biological Chemistry, 293(38), 14707-14714. https://doi.org/10.1074/jbc.RA118.004215
International DM Federation. (2019). IDF DM atlas, 9th edition. Retrieved from https://www.DMatlas.org
Jayawardena, R., Ranasinghe, P., Galappaththy, P., Malkanthi, R., Constantine, G., Katulanda, P. (2020). Effects of zinc supplementation on DM mellitus: a systematic review and meta-analysis. Diabetology & Metabolic Syndrome, 12(1), 1-11. https://doi.org/10.1186/s13098-020-00581-5
Jayawardena, R., Ranasinghe, P., Galappatthy, P., Malkanthi, R., Constantine, G. R., & Katulanda, P. (2020). Effects of zinc supplementation on glycemic control in type 2 DM mellitus: A systematic review and meta-analysis. DM, Metabolic Syndrome and Obesity: Targets and Therapy, 13, 4299-4310. doi: 10.2147/DMSO.S273522
Martins, M. D. P. S. C., Oliveira, A. S. D. S. S., Martins, M. D. C. C. E., Carvalho, V. B. L., Rodrigues, L. A. R. L., Arcanjo, D. D. R., Santos, M. A. P. D., Machado, J. S. R., & de Moura Rocha, M. (2022). Effects of zinc supplementation on glycemic control and oxidative stress in experimental DM: A systematic review. Clinical nutrition ESPEN, 51, 28–36. https://doi.org/10.1016/j.clnesp.2022.08.003
Ranasinghe, P., Jayawardena, R., Galappatthy, P., Malkanthi, R., Constantine, G., Katulanda, P. (2015). Efficacy and safety of “true cinnamon” in type 2 DM mellitus: a randomized controlled trial. DM Research and Clinical Practice, 107(2), 212-218. https://doi.org/10.1016/j.diabres.2014.11.016
Wang, Y., Li, L., Li, C., Han, Z., Yu, Z., & Li, Y. (2020). Serum zinc levels and risk of type 2 DM mellitus: A systematic review and meta-analysis. Nutrients, 12(9), 2849. doi: 10.3390/nu12092849
Published
How to Cite
Issue
Section
Copyright (c) 2023 International journal of health sciences
![Creative Commons License](http://i.creativecommons.org/l/by-nc-nd/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.